The approval of semaglutide marked a significant advancement in the pharmacological approach to managing obesity and diabetes, two of the most pressing public health concerns of our time
PlexusDx recommends setting realistic 12-month goals and tracking non-scale victories like improved energy, better blood sugar control, and clothes fitting differently
Hims is also in conversation with anybody who can bring new therapies to the platform, he added, "whether that's existing biotech or existing large drug companies." Zepbound-maker Eli Lilly is expected to launch a rival weight loss pill called orforglipron in the second quarter, pending FDA approval.
The Danish pharmaceutical company Novo Nordisk makes Wegovy
Only a minority of discussions (2.9%) focused on GLP-1 RAs that were only approved for use in diabetes mellitus
Sleep Getting enough sleep is essential to your health